This inventor holds 8 USPTO granted patents and 1 EPO patent. Top assignees: Baylor College of Medicine, Jacobus Pharmaceutical Company, Inc., Jacobus Pharmaceuticals Company, Inc.. Active years: 2000-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2000-2012
Title: Dana J Giulian: Innovator in Neurological Disease Diagnosis
Introduction
Dana J Giulian is a prominent inventor based in Houston, TX, who has made significant contributions to the field of neurological disease diagnosis. With a total of 8 patents to her name, she has focused her research on innovative methods that enhance the understanding and treatment of various neurological conditions.
Latest Patents
One of her latest patents involves methods for the diagnosis and monitoring of neurological diseases through the detection of an encephalotoxin. This encephalotoxin, produced by activated mononuclear phagocytes, is present in individuals suffering from neurological diseases, including neurodegenerative and neuro-inflammatory conditions such as Alzheimer's disease, HIV-1-associated dementia, and Creutzfeldt-Jakob disease. The biochemical detection methods she developed allow for early diagnosis of these diseases in presymptomatic stages, facilitating timely intervention and monitoring of disease progression.
Career Highlights
Throughout her career, Dana has worked with esteemed institutions, including Baylor College of Medicine and Jacobus Pharmaceuticals Company, Inc. Her work has been pivotal in advancing the understanding of neurological diseases and improving diagnostic techniques.
Collaborations
Dana has collaborated with various research institutions and companies to further her innovative work in the field of neurology.
Conclusion
Dana J Giulian's contributions to the diagnosis and monitoring of neurological diseases highlight her role as a leading inventor in this critical area of healthcare. Her innovative methods promise to enhance early intervention and improve patient outcomes in neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile